ZX-101A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZX-101A, covering 2022-03-14 to 2024-11-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies [Phase 1, Phase 2]